DZ3180A1 - Produits de médicaments à base de beta-carboline. - Google Patents

Produits de médicaments à base de beta-carboline.

Info

Publication number: DZ3180A1
Authority: DZ; Algeria
Prior art keywords: carboline; beta; products based; drug products; drug
Prior art date: 1999-08-03

Application number

DZ003180A

Other languages

English (en)

Inventor

Neil R Anderson

Kerry J Hartauer

Martha A Kral

Gregory A Stephenson

Original Assignee

Lilly Icos Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-03

Filing date

2000-08-01

Publication date

2001-02-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3180(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-01 Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc

2001-02-08 Application granted granted Critical

2001-02-08 Publication of DZ3180A1 publication Critical patent/DZ3180A1/fr

Links

AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical compound N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 title 2
229940126534 drug product Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Physical Or Chemical Processes And Apparatus (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DZ003180A 1999-08-03 2000-08-01 Produits de médicaments à base de beta-carboline. DZ3180A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14704899P	1999-08-03	1999-08-03
PCT/US2000/020981 WO2001008688A2 (fr)	1999-08-03	2000-08-01	PRODUITS DE MEDICAMENTS A BASE DE β-CARBOLINE

Publications (1)

Publication Number	Publication Date
DZ3180A1 true DZ3180A1 (fr)	2001-02-08

Family

ID=22520112

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003180A DZ3180A1 (fr)	1999-08-03	2000-08-01	Produits de médicaments à base de beta-carboline.

Country Status (33)

Country	Link
EP (1)	EP1200092B1 (fr)
JP (1)	JP4456788B2 (fr)
KR (1)	KR20020063842A (fr)
CN (2)	CN1377270A (fr)
AR (1)	AR033953A1 (fr)
AT (1)	ATE264680T1 (fr)
AU (1)	AU773666B2 (fr)
BR (1)	BR0012901A (fr)
CA (1)	CA2380087C (fr)
CO (1)	CO5200849A1 (fr)
CZ (1)	CZ300151B6 (fr)
DE (1)	DE60010089T2 (fr)
DK (1)	DK1200092T3 (fr)
DZ (1)	DZ3180A1 (fr)
EA (1)	EA004302B9 (fr)
ES (1)	ES2220506T3 (fr)
HK (1)	HK1044278B (fr)
HR (1)	HRP20020091B1 (fr)
HU (1)	HU229443B1 (fr)
IL (1)	IL147642A0 (fr)
MX (1)	MXPA02001197A (fr)
MY (1)	MY125428A (fr)
NO (1)	NO321602B1 (fr)
NZ (1)	NZ516613A (fr)
PE (1)	PE20010480A1 (fr)
PL (1)	PL199469B1 (fr)
PT (1)	PT1200092E (fr)
SK (1)	SK286365B6 (fr)
SV (1)	SV2002000137A (fr)
TW (1)	TWI235658B (fr)
UA (1)	UA71629C2 (fr)
WO (1)	WO2001008688A2 (fr)
ZA (1)	ZA200200825B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE399554T1 (de) *	1999-08-03	2008-07-15	Lilly Icos Llc	Pharmazeutische zusammensetzung enthaltend tadalafil
EP2216329A1 (fr) *	2004-10-28	2010-08-11	Dr. Reddy's Laboratories Ltd.	Procédés de préparation du tadalafil
DK1808164T3 (da)	2006-01-05	2009-04-20	Teva Pharma	Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol
DE102007028869A1 (de) *	2007-06-22	2008-12-24	Ratiopharm Gmbh	Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) *	2008-07-15	2010-08-31	Институт Химии Академии Наук Молдовы	Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de)	2009-07-16	2011-01-20	Ratiopharm Gmbh	Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de)	2009-07-29	2011-02-17	Ratiopharm Gmbh	Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (fr) *	2010-12-02	2012-06-28	Mylan Laboratories, Limited	Compositions de tadalafil
WO2012095151A1 (fr)	2010-12-23	2012-07-19	Zaklady Farmaceutyczne Polpharma Sa	Formes pharmaceutiques solides comprenant du tadalafil et ses procédés de préparation
WO2012107090A1 (fr)	2011-02-10	2012-08-16	Synthon Bv	Composition de granulés comportant du tadalafil et un délitant
WO2012107541A1 (fr)	2011-02-10	2012-08-16	Synthon Bv	Composition pharmaceutique comprenant du tadalafil et une cyclodextrine
WO2012107092A1 (fr)	2011-02-10	2012-08-16	Synthon Bv	Composition pharmaceutique comportant du tadalafil et une cyclodextrine
JP5930686B2 (ja) *	2011-12-07	2016-06-08	株式会社トクヤマ	溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
WO2013135352A1 (fr)	2012-03-15	2013-09-19	Merck Patent Gmbh	Dispositifs électroniques
WO2014003677A1 (fr) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Compositions pharmaceutiques comprenant des particules de dispersion solide contenant du tadalafil
WO2014003678A1 (fr) *	2012-06-28	2014-01-03	Xspray Microparticles Ab	Compositions pharmaceutiques comprenant de l'ambrisentan et des particules de dispersion solide contenant du tadalafil
CN105310984A (zh) *	2014-06-10	2016-02-10	合肥贝霓医药科技有限公司	一种pde5抑制剂的超微粉体及其制备方法
ES2699160T3 (es) *	2014-06-24	2019-02-07	Wooshin Labottach Co Ltd	Formulación de película de desintegración oral que contiene tadalafilo y procedimiento de preparación de la misma
EP3466951B1 (fr)	2014-07-23	2022-01-19	KRKA, d.d., Novo mesto	Procédé de préparation d'inhibiteur de cgmp-phosphodiestérase et formulation pharmaceutique orale comprenant des co-précipités de tadalafil
JP2016106139A (ja) *	2016-03-07	2016-06-16	株式会社トクヤマ	溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
JP2021509114A (ja)	2017-12-26	2021-03-18	エフティーエフファーマプライベートリミテッド	Ｐｄｅｖ阻害剤のための液体経口処方物
EP3510997B1 (fr)	2018-01-10	2020-08-05	Gap S.A.	Capsules de gélatine molle contenant une suspension de tadalafil
CN110638770B (zh) *	2019-10-25	2022-04-05	株洲千金药业股份有限公司	他达拉非片剂的制备方法及以该方法制得的片剂
EP4531815A1 (fr)	2022-05-27	2025-04-09	Rontis Hellas S.A.	Composition pharmaceutique améliorée contenant du tadalafil et procédé de nanobroyage pour sa préparation
CN119112817A (zh) *	2024-08-20	2024-12-13	武汉九珑人福药业有限责任公司	一种他达拉非片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618845A (en) *	1994-10-06	1997-04-08	Cephalon, Inc.	Acetamide derivative having defined particle size
GB9511220D0 (en) *	1995-06-02	1995-07-26	Glaxo Group Ltd	Solid dispersions

2000
- 2000-01-08 UA UA2002010773A patent/UA71629C2/uk unknown
- 2000-08-01 NZ NZ516613A patent/NZ516613A/en not_active IP Right Cessation
- 2000-08-01 WO PCT/US2000/020981 patent/WO2001008688A2/fr not_active Ceased
- 2000-08-01 DE DE60010089T patent/DE60010089T2/de not_active Expired - Lifetime
- 2000-08-01 PL PL353268A patent/PL199469B1/pl unknown
- 2000-08-01 HR HR20020091A patent/HRP20020091B1/xx not_active IP Right Cessation
- 2000-08-01 HK HK02104540.5A patent/HK1044278B/en not_active IP Right Cessation
- 2000-08-01 BR BR0012901-1A patent/BR0012901A/pt not_active Application Discontinuation
- 2000-08-01 PT PT00952371T patent/PT1200092E/pt unknown
- 2000-08-01 EP EP00952371A patent/EP1200092B1/fr not_active Expired - Lifetime
- 2000-08-01 SK SK172-2002A patent/SK286365B6/sk not_active IP Right Cessation
- 2000-08-01 DZ DZ003180A patent/DZ3180A1/fr active
- 2000-08-01 ES ES00952371T patent/ES2220506T3/es not_active Expired - Lifetime
- 2000-08-01 MX MXPA02001197A patent/MXPA02001197A/es active IP Right Grant
- 2000-08-01 HU HU0202781A patent/HU229443B1/hu unknown
- 2000-08-01 AT AT00952371T patent/ATE264680T1/de active
- 2000-08-01 CN CN00813777A patent/CN1377270A/zh active Pending
- 2000-08-01 JP JP2001513418A patent/JP4456788B2/ja not_active Expired - Lifetime
- 2000-08-01 AU AU65084/00A patent/AU773666B2/en not_active Expired
- 2000-08-01 DK DK00952371T patent/DK1200092T3/da active
- 2000-08-01 CN CNA2007101408018A patent/CN101134019A/zh active Pending
- 2000-08-01 EA EA200200119A patent/EA004302B9/ru not_active IP Right Cessation
- 2000-08-01 KR KR1020027001407A patent/KR20020063842A/ko not_active Ceased
- 2000-08-01 CZ CZ20020387A patent/CZ300151B6/cs not_active IP Right Cessation
- 2000-08-01 IL IL14764200A patent/IL147642A0/xx active IP Right Grant
- 2000-08-01 CA CA002380087A patent/CA2380087C/fr not_active Expired - Lifetime
- 2000-08-02 MY MYPI20003524 patent/MY125428A/en unknown
- 2000-08-02 CO CO00058156A patent/CO5200849A1/es not_active Application Discontinuation
- 2000-08-03 AR ARP000104015A patent/AR033953A1/es not_active Application Discontinuation
- 2000-08-03 PE PE2000000773A patent/PE20010480A1/es not_active IP Right Cessation
- 2000-08-03 TW TW089115586A patent/TWI235658B/zh not_active IP Right Cessation
- 2000-08-07 SV SV2000000137A patent/SV2002000137A/es unknown
2002
- 2002-01-30 ZA ZA200200825A patent/ZA200200825B/en unknown
- 2002-02-01 NO NO20020531A patent/NO321602B1/no unknown

Also Published As

Publication number	Publication date
CZ300151B6 (cs)	2009-02-25
SK1722002A3 (en)	2002-05-09
CO5200849A1 (es)	2002-09-27
TWI235658B (en)	2005-07-11
ATE264680T1 (de)	2004-05-15
AU6508400A (en)	2001-02-19
EP1200092B1 (fr)	2004-04-21
ES2220506T3 (es)	2004-12-16
DE60010089T2 (de)	2004-10-14
PL199469B1 (pl)	2008-09-30
HK1044278B (en)	2004-10-08
IL147642A0 (en)	2002-08-14
HRP20020091A2 (en)	2004-02-29
DK1200092T3 (da)	2004-08-16
HU229443B1 (en)	2013-12-30
PT1200092E (pt)	2004-07-30
NO20020531D0 (no)	2002-02-01
KR20020063842A (ko)	2002-08-05
CA2380087A1 (fr)	2001-02-08
CN1377270A (zh)	2002-10-30
NZ516613A (en)	2003-08-29
JP4456788B2 (ja)	2010-04-28
HK1044278A1 (en)	2002-10-18
HRP20020091B1 (en)	2006-02-28
SK286365B6 (sk)	2008-08-05
SV2002000137A (es)	2002-06-07
EA004302B1 (ru)	2004-02-26
AR033953A1 (es)	2004-01-21
MXPA02001197A (es)	2003-02-12
HUP0202781A3 (en)	2003-10-28
EP1200092A2 (fr)	2002-05-02
NO20020531L (no)	2002-04-03
JP2003505510A (ja)	2003-02-12
CN101134019A (zh)	2008-03-05
CZ2002387A3 (cs)	2002-10-16
DE60010089D1 (de)	2004-05-27
AU773666B2 (en)	2004-06-03
HUP0202781A2 (hu)	2002-12-28
ZA200200825B (en)	2003-04-30
NO321602B1 (no)	2006-06-12
UA71629C2 (en)	2004-12-15
WO2001008688A3 (fr)	2001-08-16
PL353268A1 (en)	2003-11-03
MY125428A (en)	2006-07-31
PE20010480A1 (es)	2001-05-26
CA2380087C (fr)	2007-05-01
EA200200119A1 (ru)	2002-06-27
WO2001008688A2 (fr)	2001-02-08
BR0012901A (pt)	2002-04-16
EA004302B9 (ru)	2019-01-31

Publication	Publication Date	Title
DK1200092T3 (da)	2004-08-16	Beta-carbolin-lægemiddelprodukter
MXPA03006884A (es)	2003-11-13	Formulacion farmaceutica.
IT1307266B1 (it)	2001-10-30	Apparecchio per infusione di farmaci.
ITTO20010005A1 (it)	2001-07-11	Formulazione farmaceutica.
MXPA03007641A (es)	2003-12-04	Formulacion farmaceutica.
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
MXPA03007215A (es)	2003-12-04	Formulaciones farmaceuticas.
DE122010000009I2 (de)	2012-08-09	Beta2-adrenoceptor agonisten.
AP2004003055A0 (en)	2004-06-30	Platinum derivative pharmaceutical formulations.
ES1042687Y (es)	2000-02-01	Dispositivo dispensador de articulos aplanados.
MA25291A1 (fr)	2001-12-31	Livraison de produits pharmaceutiques instables.
TR199800631A3 (tr)	1998-10-21	Ecza formülasyonu.
PT1173434E (pt)	2003-12-31	Novo produto farmaceutico
FI20000976A7 (fi)	2000-10-30	Tuotteita
DK1275397T3 (da)	2014-09-22	Lægemiddel til lokal anvendelse
IT1313579B1 (it)	2002-09-09	Composizione farmaceutica liquida a base di paracetamolo.
IT1311921B1 (it)	2002-03-20	Composti farmaceutici.
BR0006105B1 (pt)	2010-10-19	produto à base de borracha.
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
IS6163A (is)	2001-11-16	Lyfjakomplex
DZ2159A1 (fr)	2002-12-01	Produits pharmaceutiques.
ATA173599A (de)	2001-04-15	Pharmazeutisches produkt
ZA200402731B (en)	2005-01-13	Pharmaceutical formulation.
IT1307258B1 (it)	2001-10-30	Apparecchio per infusione prolungata di farmaci.
ES1042512Y (es)	2000-02-01	Percha.